7 insiders reported 53 Form 4 transactions for Tectonic Therapeutic, Inc. (TECX) over the past 18 months (most recent 2026-07-01). Recent activity: McNamara Peter (Chief Scientific Officer) Buy 172 shares, McNamara Peter (Chief Scientific Officer) Sell 172 shares, REICIN ALISE (Chief Executive Officer) Sell 924 shares, Ruddy Marcella K. (Chief Medical Officer) Sell 1,000 shares, Ruddy Marcella K. (Chief Medical Officer) Sell 10,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | McNamara Peter | Chief Scientific Officer | Buy | 172 | $2,530 |
| 2026-07-01 | McNamara Peter | Chief Scientific Officer | Sell | 172 | $6,020 |
| 2026-06-23 | REICIN ALISE | Chief Executive Officer | Sell | 924 | $28,034 |
| 2026-04-03 | Ruddy Marcella K. | Chief Medical Officer | Sell | 1,000 | $31,050 |
| 2026-03-09 | Ruddy Marcella K. | Chief Medical Officer | Sell | 10,000 | $300,000 |
| 2026-03-09 | McNamara Peter | Chief Scientific Officer | Buy | 2,500 | $5,950 |
| 2026-03-09 | McNamara Peter | Chief Scientific Officer | Buy | 215 | $3,163 |
| 2026-03-09 | McNamara Peter | Chief Scientific Officer | Sell | 6,047 | $181,410 |
| 2026-03-09 | McNamara Peter | Chief Scientific Officer | Sell | 215 | $7,525 |
| 2026-03-05 | REICIN ALISE | Chief Executive Officer | Buy | 76,500 | $0 |
| 2026-03-05 | Lochner Daniel | Chief Financial Officer | Buy | 26,500 | $0 |
| 2026-03-05 | REICIN ALISE | Chief Executive Officer | Buy | 2,500 | $52,750 |
| 2026-03-05 | McNamara Peter | Chief Scientific Officer | Sell | 1,649 | $36,377 |
| 2026-03-05 | McNamara Peter | Chief Scientific Officer | Buy | 23,000 | $0 |
| 2026-03-05 | McNamara Peter | Chief Scientific Officer | Sell | 1,650 | $41,250 |
| 2026-03-05 | Ruddy Marcella K. | Chief Medical Officer | Buy | 26,500 | $0 |
| 2026-03-05 | Schwabish Marc | Chief Business Officer | Buy | 19,500 | $0 |
| 2026-02-12 | REICIN ALISE | Chief Executive Officer | Buy | 2,500 | $52,750 |
| 2026-02-12 | Schwabish Marc | Chief Business Officer | Buy | 4,500 | $10,710 |
| 2026-02-11 | Lochner Daniel | Chief Financial Officer | Buy | 6,000 | $129,660 |
| 2026-02-10 | Schwabish Marc | Chief Business Officer | Sell | 1,619 | $37,593 |
| 2026-02-10 | REICIN ALISE | Chief Executive Officer | Sell | 4,104 | $95,295 |
| 2026-02-10 | Lochner Daniel | Chief Financial Officer | Sell | 2,077 | $48,228 |
| 2026-02-10 | Ruddy Marcella K. | Chief Medical Officer | Sell | 2,064 | $47,926 |
| 2026-02-10 | McNamara Peter | Chief Scientific Officer | Sell | 1,748 | $40,589 |
Source: SEC Form 4 filings · as of 2026-07-01